DashboardPortfolio'sControlelijstGemeenschapOntdekScreener
NOT FOR DISTRIBUTION
Loading...
  • Aandelen
  • /
  • Verzekering
1d geleden bijgewerkt
CNO logo

CNO Financial Group, Inc.NYSE:CNO Voorraadrapport

Marktkapitalisatie US$5.1b
1d geleden bijgewerkt
Prijs aandeel
n/a
1Y39.7%
7D-0.9%
1D-0.7%
Portefeuillewaarde
​
Bekijk

CNO Financial Group, Inc.

NYSE:CNO Voorraadrapport

Marktkapitalisatie: US$5.1b

  • Bedrijfsoverzicht
  • Waardering
  • Toekomstige groei
  • Prestaties in het verleden
  • Financiële gezondheid
  • Dividend
  • Beheer
  • Eigendom
  • Andere informatie
  • Aandelencommunity

CNO Financial Group (CNO) Aandelenoverzicht

CNO Financial Group, Inc. ontwikkelt, verkoopt en beheert via haar dochterondernemingen ziektekostenverzekeringen, lijfrentes, individuele levensverzekeringen en andere verzekeringsproducten, en financiële diensten voor Amerikanen met een middeninkomen en gepensioneerde Amerikanen in de Verenigde Staten. Meer informatie

CNO fundamentele analyse
Sneeuwvlok Score
Waardering0/6
Toekomstige groei2/6
Prestaties in het verleden0/6
Financiële gezondheid2/6
Dividenden4/6

Beloningen

De koers-winstverhouding ( 18.1 x) ligt onder de US markt ( 18.5 x)

De winst zal naar verwachting met 18.32% per jaar groeien

Risicoanalyse

De schulden worden niet goed gedekt door de operationele kasstroom

Grote eenmalige posten die de financiële resultaten beïnvloeden


CNO Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Analyst Price Targets

AN
AnalystConsensusTarget
2.4% overgewaardeerd intrinsieke korting
AnalystConsensusTarget
•1mo ago

Aging US Population And Digital Channels Will Expand Markets

185
0
1

Top Analyst Narratives

CNO logo
CNO Financial Group
2.4% overgewaardeerd intrinsieke korting

Aging US Population And Digital Channels Will Expand Markets

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 5 Aug
Read Narrative
View all narratives

CNO Financial Group, Inc. Concurrenten

Genworth Financial

Symbol: NYSE:GNW
Market cap: US$3.9b

Primerica

Symbol: NYSE:PRI
Market cap: US$8.9b

F&G Annuities & Life

Symbol: NYSE:FG
Market cap: US$3.2b

Lincoln National

Symbol: NYSE:LNC
Market cap: US$8.3b

Prijsgeschiedenis en prestaties

Overzicht van hoogtepunten, dieptepunten en veranderingen in de aandelenkoersen voor CNO Financial Group
Historische aandelenkoersen
Huidige aandelenkoersUS$54.80
52 Week HoogtepuntUS$57.59
52 Week LaagUS$38.22
Bèta0.81
1 maand verandering-0.89%
3 maanden verandering9.67%
1 Jaar Verandering39.69%
3 jaar verandering134.49%
5 jaar verandering129.96%
Verandering sinds IPO151.95%

Recent nieuws en updates

Seeking Alpha • Aug 21

CNO Financial: Operating Momentum Is Strong, But Valuation Looks Full

Summary CNO Financial Group demonstrates robust operating growth, with Q2 2026 revenues up 11.6% and EPS surging 45% to $1.33. Management raised 2026 EPS guidance to $4.60–$4.80, reflecting continued momentum in Medicare Supplement and workplace benefits segments. CNO trades at a premium valuation: 18.4x GAAP P/E and 1.9x P/B, both above historical and peer averages, limiting further multiple expansion. Further share price appreciation hinges on sustaining or accelerating profit growth, as the current valuation leaves a reduced safety margin. Read the full article on Seeking Alpha
User avatar
Narratiefupdate • Aug 05

CNO: Raised Guidance And Buybacks Will Support A Balanced Outlook

Analysts have modestly raised their price target on CNO Financial Group from $51.75 to $53.50, citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E multiples. What’s in the News for CNO Financial Group CNO Financial Group reported strong Q2 2026 results, with operating earnings per share up 45% and full year 2026 operating EPS guidance raised 8% at the midpoint.

Recent updates

Seeking Alpha • Aug 21

CNO Financial: Operating Momentum Is Strong, But Valuation Looks Full

Summary CNO Financial Group demonstrates robust operating growth, with Q2 2026 revenues up 11.6% and EPS surging 45% to $1.33. Management raised 2026 EPS guidance to $4.60–$4.80, reflecting continued momentum in Medicare Supplement and workplace benefits segments. CNO trades at a premium valuation: 18.4x GAAP P/E and 1.9x P/B, both above historical and peer averages, limiting further multiple expansion. Further share price appreciation hinges on sustaining or accelerating profit growth, as the current valuation leaves a reduced safety margin. Read the full article on Seeking Alpha
User avatar
Narratiefupdate • Aug 05

CNO: Raised Guidance And Buybacks Will Support A Balanced Outlook

Analysts have modestly raised their price target on CNO Financial Group from $51.75 to $53.50, citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E multiples. What’s in the News for CNO Financial Group CNO Financial Group reported strong Q2 2026 results, with operating earnings per share up 45% and full year 2026 operating EPS guidance raised 8% at the midpoint.
User avatar
Narratiefupdate • Jul 13

CNO: Record Highs And Dividend Growth Will Frame A Measured Outlook

Analysts have nudged their price target on CNO Financial Group higher from $49.50 to $51.75, citing updated fair value estimates, a slightly lower discount rate, modestly adjusted revenue growth expectations, and a higher future P/E assumption as key drivers of the change. What's in the News for CNO Financial Group CNO Financial Group stock recently reached new all time highs, trading in a range from $48.66 to $53.34, with recent price action linked to strong Q1 2026 results and analyst upgrades.
User avatar
Narratiefupdate • Jun 26

CNO: Highs, Buybacks And Dividend Increases Will Shape A Balanced Outlook

Analysts have maintained their $49.50 price target for CNO Financial Group, making only minor adjustments to assumptions around the discount rate, long term revenue growth, profit margins and future P/E that fine tune rather than significantly change their valuation view. What’s in the News for CNO Financial Group CNO Financial Group stock reached a new all time high of $51.23 after the company reported financial results for Q1 2026 that exceeded analyst expectations on both earnings per share and revenue, according to recent news reports.
User avatar
Narratiefupdate • Jun 11

CNO: Highs, Buybacks And Dividend Growth Will Support A Measured Outlook

Analysts have adjusted their price target on CNO Financial Group from $48.25 to $49.50, citing updated assumptions related to discount rates, fair value estimates, and future P/E expectations. What's in the News CNO Financial Group stock set an all time high of US$48.66 after reporting first quarter 2026 financial results that were stronger than analyst expectations for both earnings per share and revenue.
User avatar
Narratiefupdate • May 28

CNO: Steady Buybacks And Dividend Increases Will Support A Balanced Outlook

Analysts have nudged their price target on CNO Financial Group higher to $48.25 from $47.50, citing updated assumptions around fair value, discount rate, revenue growth, profit margin and future P/E multiples. What's in the News CNO Financial Group's board approved a $0.01 increase in the quarterly dividend to $0.18 per share.
User avatar
Narratiefupdate • May 09

CNO: Steady Buybacks And Dividend Increases Will Support A Balanced Outlook

Analysts have raised their price target for CNO Financial Group from $46.00 to $47.50, citing updated assumptions around discount rate, revenue growth, profit margin, and future P/E that slightly adjust their view of the stock's valuation profile. What's in the News CNO Financial Group's Board of Directors approved a $0.01 per share increase in the quarterly dividend, bringing it to $0.18 per share on common stock.
User avatar
Narratiefupdate • Apr 22

CNO: Share Repurchases And Slightly Softer Margins Will Shape A Balanced Outlook

Analysts have nudged their price target on CNO Financial Group slightly lower to $46 from $47, citing modestly softer assumptions around profit margin and future P/E, which are only partly offset by a small adjustment in the discount rate. What's in the News CNO Financial Group repurchased 1,471,754 shares from October 1, 2025 to December 31, 2025, representing 1.54% of its shares, for a total of $59.99 million (Key Developments).
User avatar
Narratiefupdate • Apr 06

CNO: Ongoing Share Repurchases Will Support An Undervalued 2025 Outlook

Analysts have adjusted their price target on CNO Financial Group slightly lower to $47. This reflects updated assumptions around fair value, discount rate and future P/E that are now a touch more conservative than before.
User avatar
Narratiefupdate • Mar 20

CNO: Ongoing Share Repurchases Will Support An Undervalued 2025 Outlook

Analysts kept their $48.00 price target for CNO Financial Group unchanged, citing consistent assumptions regarding the discount rate, revenue growth, profit margin, and forward P/E as the basis for maintaining their view. What's in the News From October 1, 2025 to December 31, 2025, CNO Financial Group repurchased 1,471,754 shares, representing 1.54% of its shares, for US$59.99 million under its ongoing buyback program (Key Developments).
User avatar
Narratiefupdate • Mar 04

CNO: Ongoing Share Repurchases Will Support An Undervalued 2025 Outlook

Analysts have nudged their price target for CNO Financial Group to $48.00, reflecting updated views on discount rates, revenue growth assumptions, profit margins, and future P/E expectations. What's in the News From October 1, 2025 to December 31, 2025, CNO Financial Group repurchased 1,500,000 shares for US$60 million, representing 1.57% of the company.
User avatar
Narratiefupdate • Feb 17

CNO: Share Repurchases And Steady Margins Will Support An Undervalued 2025 Outlook

Analysts have raised their price target on CNO Financial Group from $47.25 to $48.00, citing updated assumptions around discount rates, revenue trends, profit margins, and future P/E levels. What's in the News CNO Financial Group reported that from October 1, 2025 to December 31, 2025, it repurchased 1,500,000 shares, representing 1.57% of its shares, for US$60 million under its existing buyback program (Key Developments).
User avatar
Narratiefupdate • Feb 03

CNO: Stable Profitability And Fair Pricing Will Support A Balanced 2025 Outlook

Analysts have maintained their fair value estimate for CNO Financial Group at US$47.25, with only minor technical adjustments to assumptions such as the discount rate and future P/E informing the unchanged price target. Valuation Changes Fair Value Estimate remains unchanged at US$47.25, reflecting a consistent view of intrinsic value based on current assumptions.
User avatar
Narratiefupdate • Jan 20

CNO: Earnings Guidance And Share Repurchases Will Support A Stronger 2025 Outlook

Analysts have lifted their price target on CNO Financial Group from US$46.00 to US$47.25, citing updated assumptions around fair value, discount rate, revenue trends, profit margin and future P/E as the drivers of this refinement. What's in the News CNO Financial Group updated its earnings guidance for fiscal 2025, narrowing its operating earnings per share range to US$3.75 to US$3.85 while keeping the midpoint unchanged (Company guidance).
User avatar
Narratiefupdate • Jan 06

CNO: Earnings Guidance And Share Repurchases Will Guide Balanced 2025 Outlook

Analysts have raised their price target on CNO Financial Group from $43.75 to $46.00, citing updated assumptions regarding discount rates, revenue trends, profit margins, and future P/E expectations. What's in the News CNO Financial Group updated earnings guidance for fiscal 2025, narrowing its operating earnings per share range to $3.75 to $3.85 while keeping the midpoint unchanged (Corporate Guidance).
User avatar
Narratiefupdate • Dec 14

CNO: Earnings Guidance And Ongoing Buybacks Will Shape 2025 Performance

Analysts have slightly lowered their price target on CNO Financial Group to approximately 43.75 dollars from about 44.40 dollars. This reflects modestly higher discount rate assumptions, slightly softer long term growth expectations, and a marginally reduced future earnings multiple that still supports a solid profitability outlook.
User avatar
Narratiefupdate • Nov 27

CNO: Earnings Guidance And Continued Buybacks Will Influence 2025 Market Outlook

Analysts have raised the fair value estimate for CNO Financial Group from $43.40 to $44.40 per share, citing minor adjustments to their financial projections and underlying assumptions. What's in the News CNO Financial Group updated its earnings guidance for fiscal year 2025, narrowing the operating earnings per share range to $3.75 to $3.85.
User avatar
Narratiefupdate • Nov 11

CNO: Earnings Guidance And Buybacks Will Shape 2025 Performance Outlook

Analysts have raised their price target for CNO Financial Group by $1.00 to $43.40, citing incremental improvements in the discount rate, projected revenue decline, and profit margin estimates. What's in the News CNO Financial Group updated its earnings guidance for fiscal year 2025, narrowing its operating earnings per share range to $3.75 to $3.85 and maintaining the same midpoint (Key Developments).
Analyse-artikel • Sep 24

Take Care Before Diving Into The Deep End On CNO Financial Group, Inc. (NYSE:CNO)

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 20x, you may...
Seeking Alpha • Apr 08

CNO Financial Group: I Am Cautious Of The Immediate Future

Summary CNO Financial Group, Inc. had a strong 2024, but economic uncertainties and a potential recession in 2025 warrant a cautious outlook for the company's future performance. Despite a slight revenue decline in Q4 '24, profitability improved due to tighter claims management and better underwriting margins, with ROE reaching 17%. CNO management is optimistic for 2025, projecting $3.70-$3.90 in operating earnings and a 10.50% operating ROE, but recession risks could impact these targets. Tariffs and a potential recession could lead to reduced insurance premiums and investment losses, necessitating flexibility in customer retention and cost management. Read the full article on Seeking Alpha
User avatar
Nieuw narratief • Sep 03

Worksite Expansion And High Competition Threaten Future Profit Margins And Sales Growth

Expansion and diversification efforts might not yield expected revenue growth, impacting profit margins due to increased operational costs and investments.

Rendement voor aandeelhouders

CNOUS InsuranceUS Markt
7D-0.9%-2.6%-0.2%
1Y39.7%2.9%14.8%

Rendement versus industrie: CNO overtrof de US Insurance industrie, die het afgelopen jaar een rendement 2.9 % opleverde.

Rendement versus markt: CNO overtrof de US markt, die het afgelopen jaar een rendement opleverde van 14.8 %.

Prijsvolatiliteit

Is CNO's price volatile compared to industry and market?
CNO volatility
CNO Average Weekly Movement2.6%
Insurance Industry Average Movement4.8%
Market Average Movement6.9%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market2.9%

Stabiele aandelenkoers: CNO heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend vergeleken met de US markt.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 3% ) van CNO is het afgelopen jaar stabiel geweest.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
19793,300Gary Bhojwaniwww.cnoinc.com

CNO Financial Group, Inc. ontwikkelt, verkoopt en beheert via haar dochterondernemingen ziektekostenverzekeringen, lijfrentes, individuele levensverzekeringen en andere verzekeringsproducten en financiële diensten voor gepensioneerde Amerikanen met een middeninkomen en gepensioneerden in de Verenigde Staten. Het biedt aanvullende Medicare-verzekeringen, aanvullende ziektekostenverzekeringen en langetermijnzorgverzekeringen, levensverzekeringen en lijfrentes, evenals Medicare-voordeelplannen aan individuele consumenten via de telefoon, virtueel, online en face-to-face met agenten. Het bedrijf richt zich ook op de verkoop van vrijwillige levens- en zorgverzekeringsproducten voor bedrijven, verenigingen en andere ledengroepen door interactie met klanten op hun werkplek.

CNO Financial Group, Inc. Samenvatting

Hoe verhouden de winst en inkomsten van CNO Financial Group zich tot de beurswaarde?
CNO fundamentele statistieken
MarktkapitalisatieUS$5.11b
Inkomsten(TTM)US$279.60m
Inkomsten(TTM)US$4.65b
18.1x
Koers/Winstverhouding
1.1x
P/S-verhouding

Is CNO overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
CNO resultatenrekening (TTM)
InkomstenUS$4.65b
Kosten van inkomstenUS$2.85b
BrutowinstUS$1.80b
Overige uitgavenUS$1.52b
InkomstenUS$279.60m

Laatst gerapporteerde inkomsten

Jun 30, 2026

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)3.02
Brutomarge38.71%
Nettowinstmarge6.02%
Schuld/Eigen Vermogen Verhouding175.7%

Hoe presteerde CNO op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

1.3%
Huidig dividendrendement
23%
Uitbetalingsratio

Betaalt CNO een betrouwbaar dividend?

Zie CNO dividendgeschiedenis en benchmarks
Wanneer moet je CNO kopen om een aanstaand dividend te ontvangen?
CNO Financial Group dividenddata
Ex Dividend DatumSep 10 2026
Betaaldatum dividendSep 24 2026
Dagen tot Ex-dividend0 days
Dagen tot dividendbetaaldatum14 days

Betaalt CNO een betrouwbaar dividend?

Zie CNO dividendgeschiedenis en benchmarks

Bedrijfsanalyse en status van financiële gegevens

GegevensLaatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse2026/09/09 04:42
Aandelenkoers aan het einde van de dag2026/09/09 00:00
Inkomsten2026/06/30
Jaarlijkse inkomsten2025/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

PakketGegevensTijdframeVoorbeeld Amerikaanse bron *
Financiële gegevens bedrijf10 jaar
  • Resultatenrekening
  • Kasstroomoverzicht
  • Balans
  • SEC-formulier 10-K
  • SEC-formulier 10-Q
Consensus schattingen analisten+3 jaar
  • Financiële prognoses
  • Koersdoelen analisten
  • Onderzoeksrapporten van analisten
  • Blue Matrix
Marktprijzen30 jaar
  • Aandelenprijzen
  • Dividenden, splitsingen en acties
  • ICE Marktgegevens
  • SEC-formulier S-1
Eigendom10 jaar
  • Top aandeelhouders
  • Handel met voorkennis
  • SEC-formulier 4
  • SEC-formulier 13D
Beheer10 jaar
  • Leiderschapsteam
  • Raad van bestuur
  • SEC-formulier 10-K
  • SEC-formulier DEF 14A
Belangrijkste ontwikkelingen10 jaar
  • Bedrijfsaankondigingen
  • SEC-formulier 8-K

* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.

Analysemodel en Snowflake

Details van het analysamodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.

Leer meer over het dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.

Bronnen van analisten

CNO Financial Group, Inc. wordt gevolgd door 15 analisten. 2 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

AnalistInstelling
Jack MattenBMO Capital Markets Equity Research
Randy BinnerB. Riley Securities, Inc.
Mark PalmerBTIG

Neem overal betere beleggingsbeslissingen

Scan om te downloaden
Open App StoreGoogle Play openen
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
Gegevensbronnen bekijken
Markten
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Beleggingsideeën
  • Ondergewaardeerde bedrijven
  • Dividendkrachtpatsers
  • Kopen met voorkennis
  • Kernenergie
  • Autonome voertuigen
  • Kunstmatige intelligentie
  • Crypto en blockchain
  • Cyberbeveiliging
  • Meer ideeën
Voorraad Gemeenschappen
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Functies en gereedschappen
  • Portfolio Volger
  • Aandelen screener & waarschuwingen
  • Diverse en eerlijke waarden
  • Dividend berekenen
Nieuws & Ontdekkingen
  • Laatste voorraadnieuws
  • Globale markt Inzichten
  • De Foxhole
  • Beleggingsideeën
  • Community nominale waarden
  • Nieuw
Simply Wall St
  • Plannen en prijzen
  • Adverteren
  • Over ons
  • Neem contact met ons op
  • Carrière
  • Helpcentrum
  • Leren beleggen in aandelen
  • Affiliate programma
  • Bedrijf & Onderneming
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Algemene voorwaarden
  • Privacybeleid
  • AI-voorwaarden
  • Gids voor financiële diensten